Assessment of the lipid lowering agents on plasma homocysteine concentration and renal function

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN22151635

Enrollment

Registered

2004-09-30

Start date

2003-11-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Hyperlipidemia Circulatory System Hyperlipidemia

Interventions

3 groups: 1. Group 1 = Fibrate 1 2. Group 2 = Fibrate 2 3. Group 3 = Statin (Control)

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients attending the lipid clinic with raised cholesterol and triglycerides

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Measurements of renal function, plasma homocysteine and lipids over an 8 month period	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026